All Curated Mutation Sites in EBV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in EBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
LMP-1
  
BZLF1
  
EBNA-1
  
EBNA-2
  
EBNA-3A
  
EBNA-3B/EBNA-3C
  
LMP-2A
  
LMP-2
  
EBNA-2
  
BARF1
  
BALF2
  
BXLF1
  
BPLF1
  
BcRF1
  
BFRF2
  
BILF1
  
BLLF1
  
BMRF1
  
BNRF1
  
BOLF1
  
BRRF2
  
LF1
  

Keyword: Stomach Neoplasms-22348267
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 22348267 P291T
EBNA-2
EBNA-2
Stomach Neoplasms
Nasopharyngeal Carcinoma
L
View
2 22348267 R163M
EBNA-2
EBNA-2
Stomach Neoplasms
Nasopharyngeal Carcinoma
L
View
3 22348267 R413G
EBNA-2
EBNA-2
Stomach Neoplasms
Nasopharyngeal Carcinoma
L
View
4 22348267 G48991T
EBNA-2
EBNA-2
Stomach Neoplasms
Nasopharyngeal Carcinoma
L
View
5 22348267 C48998A
EBNA-2
EBNA-2
Stomach Neoplasms
Nasopharyngeal Carcinoma
L
View
6 22348267 T49613A
EBNA-2
EBNA-2
Stomach Neoplasms
Nasopharyngeal Carcinoma
L
View
7 22348267 357delK
EBNA-2
EBNA-2
Stomach Neoplasms
Nasopharyngeal Carcinoma
L
View
8 22348267 358delG
EBNA-2
EBNA-2
Stomach Neoplasms
Nasopharyngeal Carcinoma
L
View
9 22348267 294delQ
EBNA-2
EBNA-2
Stomach Neoplasms
Nasopharyngeal Carcinoma
L
View
Contents
Description

The table shows all curated mutation sites of EBV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.